The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people age 55 and older with cognitive decline.
The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are likely or unlikely to have Alzheimer’s-related brain changes.
The VPodDuoss (the ‘V’ stands for virus)— can read and compare results from a variety of tests for pathogens or cancer-associated biomarkers.
It’s the brainchild of Lee, University of Illinois Urbana-Champaign Computer Engineering Professor Brian Cunningham, PhD, and Bioengineering Professor Xing Wang, PhD,…
Atherosclerosis, the process underlying most cardiovascular diseases, begins long before the first symptoms appear.
An international study led by Professor Henning Bundgaard, Professor of Cardiology at Rigshospitalet in Copenhagen, Denmark, and Dr Borja Ibáñez, Scientific Director of the Centro Nacional…
Attendees
Sponsors and Exhibitors
Contact us